cpeedahsa
Century Club
Joined: 21 Apr 2007
Posts: 922
|
 Posted: Thu May 31, 2007 4:21 pm Post subject: Drugs and Licensing information |
 |
|
Reference- Weeks, Andrew D., Fiala, Christian & Safar, Peter- .Misoprostol and the debate over off-label drug use. BJOG: An International Journal of Obstetrics & Gynaecology 112 (3), 269-272
Summary of the status of six drugs for particular clinical indications. Licensing information is taken from Medicines Compendium 2003 (ABPI). In the 'BNF' column, drugs get a tick if mentioned as a management option under that drugs entry in the British National Formulary.11 In the 'RCOG' column, a tick is obtained if the drug is mentioned as an option in Royal College of Obstetricians and Gynaecologists guidelines (or that of an approved affiliate in the case of PPH).
Drug and indication
1. Oxytocin 10 im to prevent PPH  Licensed X BNF RCOG
2. Misoprostol for termination of pregnancy before 24 weeks Licensed X BNF RCOG
3. Antenatal betamethasone to prevent neonatal respiratory distress syndrome in premature deliveries LicensedX BNF X RCOG
4. Clindamycin to treat beta haemolytic streptococci in pregnancy Licensed X BNF X RCOG
5. Oxytocin 5 iv to treat missed miscarriage Licensed BNFX RCOG X
6. Norethisterone (days 19–26) to treat menorrhagia LicensedBNF RCOG X[/quote] |
|
FAQ
Search
Memberlist
Usergroups
Register
Profile
Log in to check your private messages
Log in
